-
Nirsevimab for RSV Prevention in Hong Kong Infants: A Cost-Effectiveness Analysis
Mar 10, 2025, 14:00 PM -
Evaluation of Availability, Prices, and Affordability of Medicines for Hepatitis B and Hepatitis C Viruses at Community Pharmacies in a Senatorial District in North-Central Nigeria
Mar 10, 2025, 14:00 PM -
Assessing Health-Related Quality of Life Using the EQ-5D-5L Among Hong Kong Adult Population: The Role of Lifestyle Behaviours
Mar 10, 2025, 14:00 PM -
Assessing the Relationship Between Pruritus and Work Productivity Among Individuals With PBC and Pruritus: Results From the ITCH-E Study
Mar 10, 2025, 14:00 PM -
Assessing the Impact of Disparity on Hospital Outcomes: Review of 5 Diseases and their Unique Challenges
Mar 10, 2025, 14:00 PM -
Renal Cell Carcinoma and Muscle Invasive Bladder Cancer Patients' Perception of Risk and Fear of Recurrence
Mar 10, 2025, 14:00 PM -
Assessing Overall Survival and Treatment Impact in Progressive Multifocal Leukoencephalopathy
Mar 10, 2025, 14:00 PM -
Staffing Resource Use: A Cost Impact Model for the Utilization and Implementation of Medications for Opioid Use Disorder Within US Jails And Prisons
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Adults 60 Years of Age and Older in Japan
Mar 10, 2025, 14:00 PM -
PICC Line (PICC) or Central Inserted Venous Catheter (CICC ) in Cancer Patients: Comparative Effectiveness and Cost-Effectiveness Analysis in Brasil/LATAM/LMIC
Mar 10, 2025, 14:00 PM -
Early Breast Cancer in the US and Germany: A Comparison of Real-world Screening and Treatment
Mar 10, 2025, 14:00 PM -
The Real-World Cost-Effectiveness of Faricimab Versus Existing and Future Biosimilars in Patients with Neovascular Age-Related Macular Degeneration in Canada
Mar 10, 2025, 14:00 PM -
Progression-Free Survival (PFS) as a Surrogate for Overall Survival (OS) in the Front-Line Maintenance Setting for Advanced Ovarian Cancer (OC): A Trial-Level Meta-Analysis
Mar 10, 2025, 14:00 PM -
Developing and Evaluating Definitions of Real-World (rw) Clinical Endpoints for Patients with Early-Stage Triple Negative Breast Cancer (esTNBC) Using a US Secondary Database
Mar 10, 2025, 14:00 PM -
Analysis of the Human Development Index by Innovation In Health, Through the Incorporation of New Technologies In Oncology: Preliminary Data in LMIC/LATAM/Brazil
Mar 10, 2025, 14:00 PM -
Impact of Emicizumab on Quality of Life and Clinical Outcomes in Patients with Hemophilia A in Guatemala
Mar 10, 2025, 14:00 PM -
Global, Regional, and National Burdens of Type 1 and Type 2 Diabetes Mellitus in Adolescents from 1990 to 2021, with Forecasts to 2030: A Systematic Analysis of the Global Burden of Disease Study 2021
Mar 10, 2025, 14:00 PM -
Frequently Asked Questions (FAQs): What Are the Risks and Mitigation Strategies in Using Gen-AI in HEOR?
Mar 10, 2025, 14:00 PM -
Development of a Conceptual Model of the Patient Experience with Idiopathic Hypersomnia: Patient Interviews from a Clinical Trial (NCT05156047)
Mar 10, 2025, 14:00 PM -
Psychometric Validation and Meaningful Within-Patient Change of the FAACT-5IASS in Patients With Cancer Cachexia
Mar 10, 2025, 14:00 PM
